Literature DB >> 30605716

Modulation of radiation sensitivity and antitumor immunity by viral pathogenic factors: Implications for radio-immunotherapy.

Franz Rödel1, Daniel Martin2, Panagiotis Balermpas3, Ulrike Wieland4, Ria Winkelmann5, Thorsten Riekmann6, Stephan Falk7, Claus Rödel3, Emmanouil Fokas3.   

Abstract

Several DNA viruses including Human Papillomavirus (HPV), Epstein-Barr virus (EBV), and Human cytomegalovirus (HCMV) are mechanistically associated with the development of human cancers (HPV, EBV) and/or modulation of the immune system (HCMV). Moreover, a number of distinct mechanisms have been described regarding the modulation of tumor cell response to ionizing radiation and evasion from the host immune system by viral factors. There is further accumulating interest in the treatment with immune-modulatory therapies such as immune checkpoint inhibitors for malignancies with a viral etiology. Also, patients with HPV-positive tumors have a significantly improved prognosis that is attributable to increased intrinsic radiation sensitivity and may also arise from modulation of a cytotoxic T cell response in the tumor microenvironment (TME). In this review, we will highlight recent advances in the understanding of the biological basis of radiation response mediated by viral pathogenic factors and evasion from and modulation of the immune system by viruses.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-tumor immunity; Epstein-Barr virus; Human Papillomavirus; Human cytomegalovirus; Radio-immunotherapy; Viral pathogenic factors

Mesh:

Substances:

Year:  2018        PMID: 30605716     DOI: 10.1016/j.bbcan.2018.12.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  6 in total

1.  HPV Status and Individual Characteristics of Human Papillomavirus Infection as Predictors for Clinical Outcome of Locally Advanced Cervical Cancer.

Authors:  Liana Mkrtchian; Irina Zamulaeva; Liudmila Krikunova; Valentina Kiseleva; Olga Matchuk; Liubov Liubina; Gunel Kulieva; Sergey Ivanov; Andrey Kaprin
Journal:  J Pers Med       Date:  2021-05-27

Review 2.  Enhanced Radiation Sensitivity of Human Papillomavirus-Driven Head and Neck Cancer: Focus on Immunological Aspects.

Authors:  Mine Özcan-Wahlbrink; Christoph Schifflers; Angelika B Riemer
Journal:  Front Immunol       Date:  2019-12-03       Impact factor: 7.561

3.  Head and neck tumor cells treated with hypofractionated irradiation die via apoptosis and are better taken up by M1-like macrophages.

Authors:  Hanna Wedekind; Kristina Walz; Mayte Buchbender; Thorsten Rieckmann; Erwin Strasser; Fridolin Grottker; Rainer Fietkau; Benjamin Frey; Udo S Gaipl; Michael Rückert
Journal:  Strahlenther Onkol       Date:  2021-10-19       Impact factor: 3.621

4.  The routine use of LCD-Array hybridisation technique for HPV subtyping in the diagnosis of penile carcinoma compared to other methods.

Authors:  Stefan Vallo; Melanie Demes; Ria Winkelmann; Katrin Bankov; Jens von der Grün; Jindrich Cinatl; Peter J Wild
Journal:  BMC Urol       Date:  2022-01-29       Impact factor: 2.264

5.  Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer.

Authors:  Marcus Wurlitzer; Nikolaus Möckelmann; Malte Kriegs; Maren Vens; Maryam Omidi; Konstantin Hoffer; Clara von Bargen; Christina Möller-Koop; Melanie Witt; Conrad Droste; Agnes Oetting; Hannes Petersen; Chia-Jung Busch; Adrian Münscher; Hartmut Schlüter; Till Sebastian Clauditz; Thorsten Rieckmann
Journal:  Cancers (Basel)       Date:  2020-06-11       Impact factor: 6.639

6.  Editorial: Radioimmunotherapy-Translational Opportunities and Challenges.

Authors:  Udo S Gaipl; Gabriele Multhoff; A Graham Pockley; Franz Rödel
Journal:  Front Oncol       Date:  2020-02-21       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.